Financial Ratios Baosheng Science and Technology Innovation Co.,Ltd.
Stocks
600973
CNE000001KL0
Electrical Components & Equipment
|
End-of-day quote
Shanghai S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 6.190 CNY | +1.31% |
|
-0.32% | -15.21% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.56 | 1.45 | 1.53 | -0.09 | 1.49 | |||||
Return on Total Capital | 3.04 | 1.74 | 1.92 | -0.12 | 1.97 | |||||
Return On Equity % | -12.22 | 1.35 | 0.93 | -7.09 | -0.38 | |||||
Return on Common Equity | -17.76 | 1.75 | 0.83 | -8.37 | -1.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.38 | 5.11 | 5.29 | 4.38 | 4.21 | |||||
SG&A Margin | 2.07 | 1.94 | 1.99 | 1.95 | 1.59 | |||||
EBITDA Margin % | 3.04 | 2.38 | 2.45 | 1.17 | 1.87 | |||||
EBITA Margin % | 2.04 | 1.26 | 1.29 | -0.01 | 1.1 | |||||
EBIT Margin % | 1.99 | 1.18 | 1.22 | -0.07 | 1.04 | |||||
Income From Continuing Operations Margin % | -1.51 | 0.16 | 0.1 | -0.7 | -0.03 | |||||
Net Income Margin % | -1.78 | 0.16 | 0.07 | -0.65 | -0.09 | |||||
Net Avail. For Common Margin % | -1.78 | 0.16 | 0.07 | -0.65 | -0.09 | |||||
Normalized Net Income Margin | 0.23 | 0.11 | 0.08 | -0.42 | 0.1 | |||||
Levered Free Cash Flow Margin | 1.04 | 1.1 | -0.57 | -1.66 | 1.25 | |||||
Unlevered Free Cash Flow Margin | 1.83 | 1.88 | 0.11 | -1.03 | 1.73 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.06 | 1.97 | 2.01 | 2.14 | 2.29 | |||||
Fixed Assets Turnover | 7.56 | 7.17 | 7.59 | 9.48 | 12.31 | |||||
Receivables Turnover (Average Receivables) | 6.63 | 6.64 | 6.42 | 6.46 | 6.77 | |||||
Inventory Turnover (Average Inventory) | 15.47 | 14.71 | 13.72 | 13.1 | 12.79 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.02 | 0.97 | 1.08 | 1 | 1.09 | |||||
Quick Ratio | 0.73 | 0.74 | 0.77 | 0.69 | 0.69 | |||||
Operating Cash Flow to Current Liabilities | 0.03 | 0.03 | 0.09 | -0.06 | 0.06 | |||||
Days Sales Outstanding (Average Receivables) | 55.06 | 54.93 | 56.89 | 56.64 | 53.93 | |||||
Days Outstanding Inventory (Average Inventory) | 23.59 | 24.81 | 26.6 | 27.95 | 28.53 | |||||
Average Days Payable Outstanding | 12.66 | 11.69 | 18.41 | 24.83 | 27.1 | |||||
Cash Conversion Cycle (Average Days) | 66 | 68.05 | 65.08 | 59.76 | 55.36 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 279.29 | 257.75 | 252.44 | 294.31 | 257.12 | |||||
Total Debt / Total Capital | 73.64 | 72.05 | 71.63 | 74.64 | 72 | |||||
LT Debt/Equity | 59.12 | 38.88 | 66.15 | 46.55 | 59.24 | |||||
Long-Term Debt / Total Capital | 15.59 | 10.87 | 18.77 | 11.81 | 16.59 | |||||
Total Liabilities / Total Assets | 77.57 | 77.1 | 77.79 | 80.22 | 79.44 | |||||
EBIT / Interest Expense | 1.57 | 0.94 | 1.13 | -0.07 | 1.37 | |||||
EBITDA / Interest Expense | 2.42 | 1.95 | 2.27 | 1.21 | 2.51 | |||||
(EBITDA - Capex) / Interest Expense | 1.19 | 1.07 | 1.12 | 0.58 | 1.85 | |||||
Total Debt / EBITDA | 9.88 | 12.4 | 11.65 | 21.6 | 12.22 | |||||
Net Debt / EBITDA | 6.95 | 8.46 | 8.09 | 16.56 | 9.04 | |||||
Total Debt / (EBITDA - Capex) | 20.06 | 22.66 | 23.54 | 45.13 | 16.55 | |||||
Net Debt / (EBITDA - Capex) | 14.12 | 15.47 | 16.36 | 34.6 | 12.25 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 25.07 | -3.51 | 5.58 | 5.85 | 3.45 | |||||
Gross Profit, 1 Yr. Growth % | 12.49 | -23.22 | 9.25 | -12.24 | -0.73 | |||||
EBITDA, 1 Yr. Growth % | 8.13 | -24.64 | 10.57 | -49.2 | 62.33 | |||||
EBITA, 1 Yr. Growth % | 5.12 | -40.89 | 12.57 | -100.8 | 14.25K | |||||
EBIT, 1 Yr. Growth % | 7.05 | -42.71 | 15.03 | -105.91 | -1.7K | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -344.23 | -109.98 | -29.84 | -807.28 | -95.07 | |||||
Net Income, 1 Yr. Growth % | -435.91 | -108.49 | -52.52 | -1.07K | -85.36 | |||||
Normalized Net Income, 1 Yr. Growth % | -44.89 | -55.15 | 26.52 | -698.69 | -125.72 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -429.41 | -108.93 | -60 | -1.2K | -86.36 | |||||
Accounts Receivable, 1 Yr. Growth % | -18.44 | 12.37 | 6.18 | 4.66 | -6.32 | |||||
Inventory, 1 Yr. Growth % | 11.02 | -4.52 | 31.35 | -2.78 | 19.05 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.38 | -1.07 | 0.49 | -30.82 | -5.18 | |||||
Total Assets, 1 Yr. Growth % | -0.47 | 1.57 | 5.63 | -6.93 | 1.72 | |||||
Tangible Book Value, 1 Yr. Growth % | -33.6 | 4.51 | 0.76 | -8.93 | 13.32 | |||||
Common Equity, 1 Yr. Growth % | -27.3 | 2.7 | 0.3 | -9.16 | 8.33 | |||||
Cash From Operations, 1 Yr. Growth % | -377.39 | -11.42 | 210.38 | -169.55 | -194.1 | |||||
Capital Expenditures, 1 Yr. Growth % | -39.15 | -31.71 | 19.29 | -46.25 | -18.22 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -145 | 5.06 | -156.52 | 135.35 | -184.72 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -211.72 | 0.71 | -93.63 | 1.54K | -297.89 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.5 | 10 | 0.94 | 5.72 | 4.64 | |||||
Gross Profit, 2 Yr. CAGR % | 12.41 | -6.63 | -8.42 | -2.09 | -6.67 | |||||
EBITDA, 2 Yr. CAGR % | 11.73 | -9.42 | -9.57 | -25.03 | -8.51 | |||||
EBITA, 2 Yr. CAGR % | 8.66 | -20.87 | -19.88 | -90.51 | -3.7 | |||||
EBIT, 2 Yr. CAGR % | 9.68 | -21.65 | -20.86 | -74.08 | -2.65 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 84.34 | -50.66 | -73.42 | 122.76 | -40.94 | |||||
Net Income, 2 Yr. CAGR % | 122.57 | -46.61 | -79.83 | 114.23 | 18.94 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.89 | -50.33 | -39.06 | 159.97 | 24.1 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 107.55 | -45.77 | -81.1 | 109.76 | 22.47 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.81 | -3.77 | 9.23 | 5.42 | -0.98 | |||||
Inventory, 2 Yr. CAGR % | 29.12 | 3.09 | 11.99 | 13 | 6.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.17 | 1.79 | -0.29 | -16.62 | -19.01 | |||||
Total Assets, 2 Yr. CAGR % | 10.55 | 0.82 | 3.6 | -0.85 | -2.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | -5.91 | -16.29 | 2.62 | -4.21 | 0.88 | |||||
Common Equity, 2 Yr. CAGR % | -2.68 | -13.27 | 1.5 | -4.54 | -1.31 | |||||
Cash From Operations, 2 Yr. CAGR % | 199.89 | 59.17 | 65.81 | 46.93 | -19.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | -10.32 | -35.47 | -9.74 | -19.93 | -33.7 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 23.14 | -32.23 | -24.41 | 32.19 | 35.82 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 569.72 | 5.24 | -74.92 | -21.07 | 433.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | 18.82 | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.04 | 7.62 | 8.51 | 2.55 | 4.96 | |||||
Gross Profit, 3 Yr. CAGR % | 11.29 | -0.7 | -1.61 | -9.71 | -1.64 | |||||
EBITDA, 3 Yr. CAGR % | 11.23 | -1.79 | -3.8 | -25.37 | -2.52 | |||||
EBITA, 3 Yr. CAGR % | 7.76 | -11.07 | -12.06 | -82.75 | 1.49 | |||||
EBIT, 3 Yr. CAGR % | 8.51 | -11.64 | -12.45 | -66.8 | 2.52 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 63.9 | -30.29 | -44.35 | -20.66 | -37.45 | |||||
Net Income, 3 Yr. CAGR % | 86.46 | -25.09 | -48.5 | -26.74 | -12.42 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.43 | -27.05 | -41.1 | 25.66 | 20.24 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 80.01 | -27.28 | -51 | -26.76 | -15.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.47 | 3.05 | -0.56 | 7.69 | 1.35 | |||||
Inventory, 3 Yr. CAGR % | 15.34 | 16.86 | 11.76 | 6.83 | 14.31 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.33 | 7.69 | 1.36 | -11.73 | -12.97 | |||||
Total Assets, 3 Yr. CAGR % | 7.6 | 7.67 | 2.41 | -0.04 | -0.09 | |||||
Tangible Book Value, 3 Yr. CAGR % | -1.96 | -2.24 | -10.95 | -1.38 | 0.84 | |||||
Common Equity, 3 Yr. CAGR % | -0.42 | -0.68 | -8.96 | -2.18 | -0.77 | |||||
Cash From Operations, 3 Yr. CAGR % | -19.25 | 101.76 | 98.85 | 24.12 | 26.65 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.86 | -18.05 | -20.81 | -24.06 | -19.36 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -38.98 | 15.67 | -37.02 | 20.89 | 11.05 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -21.97 | 254.28 | -58.95 | -14.95 | 2.73 | |||||
Dividend Per Share, 3 Yr. CAGR % | 18.29 | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 23.17 | 14.92 | 6.36 | 6.85 | 6.94 | |||||
Gross Profit, 5 Yr. CAGR % | 16.8 | 7.09 | 3.13 | -1.26 | -3.67 | |||||
EBITDA, 5 Yr. CAGR % | 13.75 | 7.72 | 2.53 | -12.18 | -5.7 | |||||
EBITA, 5 Yr. CAGR % | 11.1 | 2.55 | -4.14 | -63.93 | -8.79 | |||||
EBIT, 5 Yr. CAGR % | 11.04 | 2.33 | -4.34 | -46.45 | -8.87 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 19 | -5.62 | -20.85 | 11.14 | -43.01 | |||||
Net Income, 5 Yr. CAGR % | 23.49 | -5.57 | -23.41 | 14.25 | -28.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | -10.82 | -9.8 | -12.02 | 11.42 | -22.43 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 20.47 | -6.77 | -26.93 | 11.1 | -29.31 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.7 | -0.37 | 4.1 | 3.99 | -0.73 | |||||
Inventory, 5 Yr. CAGR % | 21.59 | 11.18 | 14.04 | 15.3 | 9.68 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.07 | 10.58 | 7.18 | -2.78 | -7.34 | |||||
Total Assets, 5 Yr. CAGR % | 13.26 | 7.57 | 6.09 | 4.18 | 0.28 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3 | -0.11 | 0.05 | -3.03 | -6.39 | |||||
Common Equity, 5 Yr. CAGR % | 0.08 | 0.54 | 0.49 | -2.24 | -5.97 | |||||
Cash From Operations, 5 Yr. CAGR % | -22.89 | -23.95 | 8.34 | 77.72 | 38.77 | |||||
Capital Expenditures, 5 Yr. CAGR % | 16.6 | -10.75 | -2.92 | -18.81 | -26.24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -16.84 | -35.43 | -33.91 | 21.08 | -9.55 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -9.33 | -27.3 | -50.6 | 93.55 | 3.32 | |||||
Dividend Per Share, 5 Yr. CAGR % | -6.37 | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
















